Insider Trading activities of Rigel Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Rigel Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Rigel Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Rigel Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is RIGL. The reporting company's CIK number is 1034842.
The total value of stock buying since 2005 is $5,455,482.
The total value of stock sales since 2005 is $10,241,720.
The total value of stock option exercises since 2005 is $1,052,175.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Rigel Pharmaceuticals Inc (RIGL).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-11 0 $0 100,000 $390,000 100,000 $214,000
2017-07 0 $0 5,000 $13,425 0 $0
2017-01 0 $0 5,000 $12,030 0 $0
2016-08 0 $0 5,303 $21,212 0 $0
2015-06 0 $0 41,666 $153,205 41,666 $89,165
2015-04 0 $0 10,000 $37,520 0 $0
2014-12 0 $0 1,000 $2,220 0 $0
2014-09 0 $0 20,000 $51,200 0 $0
2014-02 0 $0 20,000 $74,240 0 $0
2013-11 0 $0 484,622 $1,280,371 0 $0
2013-06 32,700 $113,403 0 $0 0 $0
2012-09 0 $0 102,453 $1,085,289 98,302 $637,977
2012-08 0 $0 1,700 $18,043 1,700 $11,033
2012-06 0 $0 10,000 $87,210 0 $0
2011-05 650,000 $5,200,000 0 $0 0 $0
2010-11 0 $0 38,555 $291,090 0 $0
2009-01 0 $0 0 $0 53,334 $96,001
2007-08 10,000 $98,620 0 $0 0 $0
2007-06 0 $0 0 $0 2,222 $3,999
2007-05 2,000 $19,350 0 $0 0 $0
2005-12 1,000 $8,119 0 $0 0 $0
2005-07 0 $0 327,026 $6,724,665 0 $0
2005-03 1,000 $15,990 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Rigel Pharmaceuticals Inc insiders (RIGL)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-11-03 Maynard Ryan D (EVP & CFO) Sale 100,000 3.90 390,000
2017-11-03 Maynard Ryan D (EVP & CFO) Option Ex 100,000 2.14 214,000
2017-07-05 Duliege Anne-marie (Chief Medical Officer) Sale 5,000 2.69 13,425
2017-01-03 Duliege Anne-marie (Chief Medical Officer) Sale 5,000 2.41 12,030
2016-08-30 Payan Donald G (EVP, Pres. Discovery&Research) Sale 5,303 4.00 21,212
2015-06-10 Payan Donald G (EVP, Pres. Discovery&Research) Sale 41,666 3.68 153,205
2015-06-10 Payan Donald G (EVP, Pres. Discovery&Research) Option Ex 41,666 2.14 89,165
2015-04-01 Payan Donald G (EVP, Pres. Discovery&Research) Sale 10,000 3.75 37,520
2014-12-18 Vance Dolly (EVP Corp. Affairs, G.C., Sect.) Sale 1,000 2.22 2,220
2014-09-03 Payan Donald G (EVP, Pres. Discovery&Research) Sale 20,000 2.56 51,200
2014-02-24 Payan Donald G (EVP, Pres. Discovery&Research) Sale 20,000 3.71 74,240
2013-11-19 Bvf Investments Llc (Other) Sale 484,622 2.64 1,280,371
2013-06-07 Lampert Mark N (10% Owner) Buy 32,700 3.47 113,403
2012-09-13 Vance Dolly (EVP Corp. Affairs, G.C., Sect.) Sale 4,151 10.43 43,282
2012-09-10 Maynard Ryan D (EVP & CFO) Sale 17,586 10.52 184,934
2012-09-10 Maynard Ryan D (EVP & CFO) Option Ex 17,586 6.49 114,133
2012-09-07 Maynard Ryan D (EVP & CFO) Sale 57,414 10.61 608,511
2012-09-07 Maynard Ryan D (EVP & CFO) Option Ex 57,414 6.49 372,615
2012-08-07 Maynard Ryan D (EVP & CFO) Sale 1,700 10.61 18,043
2012-08-07 Maynard Ryan D (EVP & CFO) Option Ex 1,700 6.49 11,033
2012-06-19 Payan Donald G (EVP, Pres. Discovery&Research) Sale 10,000 8.72 87,210
2011-05-26 Deerfield International Ltd Buy 650,000 8.00 5,200,000
2010-11-03 Deerfield Special Situations Fund International Ltd Sale 23,133 7.55 174,654
2009-01-02 Payan Donald G (EVP, Pres. Discovery&Research) Option Ex 3,334 1.80 6,001
2009-01-02 Gower James M (CEO & Board Chairman) Option Ex 50,000 1.80 90,000
2007-08-09 Goodwin Bradford S Buy 10,000 9.86 98,620
2007-06-26 Moos Walter H Option Ex 2,222 1.80 3,999
2007-05-29 Grossbard Elliott B (Sr. VP Medical Development) Buy 2,000 9.68 19,350
2005-12-07 Cooper Robin D G (Sr. V.P. Pharmaceuti) Buy 1,000 8.12 8,119
2005-07-27 Deleage Jean (Director) Sale 171,997 20.40 3,509,082
2005-07-25 Deleage Jean (Director) Sale 6,400 20.37 130,348
2005-07-21 Deleage Jean (Director) Sale 586 20.75 12,159
2005-07-20 Deleage Jean (Director) Sale 148,043 20.76 3,073,076
2005-03-30 Vance Dolly (Gen.Counsel) Buy 1,000 15.99 15,990

Insider trading activities including stock purchases, stock sales, and option exercises of RIGL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Rigel Pharmaceuticals Inc (symbol RIGL, CIK number 1034842) see the Securities and Exchange Commission (SEC) website.